Literature DB >> 25311207

Remarkable Activation of the Complement System and Aberrant Neuronal Localization of the Membrane Attack Complex in the Brain Tissues of Scrapie-Infected Rodents.

Yan Lv1,2, Cao Chen1,2, Bao-Yun Zhang1, Kang Xiao1, Jing Wang1,2, Li-Na Chen1, Jing Sun1, Chen Gao1,2, Qi Shi1,2, Xiao-Ping Dong3,4,5.   

Abstract

As an integral part of the innate immunity, the complement system has been reported to involve in the pathogenesis of prion diseases (PrD). However, the states of expression and activity of complement proteins in experimental models of scrapie infection are still not fully understood. Herein, the state of complement activation, the presence, and distribution as well as localization of C3 and membrane attack complex (MAC) in the brains of several scrapie-infected rodents were comparatively assessed through various methodologies. Our data illustrated a significant increase in the total complement activity (CH50, U/ml) in several scrapie-infected rodent brains at the terminal stage and a time-dependent upregulation of C1q in 263K-infected hamsters during the incubation period, intimating the sustained and progressive activation of the classical pathway during PrD progression. Confocal microscopy revealed robust activation of C3 and its localization to various central nervous system (CNS) cells with differential morphology in the brain tissues of both 263K-infected hamsters and 139A-infected C57BL/6 mice at disease end stages. Dynamic analyses of MAC in the brains of 263K-infected hamsters and 139A-infected C57BL/6 mice demonstrated remarkably time-dependent deposition during the incubation period, which may highlight a persistently activated terminal complement components. Moreover, immunofluorescent assays (IFAs) showed that MAC-specific signals appeared to overlap with morphologically abnormal neurons rather than proliferative astrocytes or activated microglia throughout the CNS of both 263K-infected hamsters and 139A-infected C57BL/6 mice. Overall, these results indicate that the activation of the complement system and the subsequent localization of the complement components to neurons may be a hallmark during prion infection, which ultimately contribute to the neurodegeneration in PrD.

Entities:  

Keywords:  C1q; C3; CH50; Complement; Membrane attack complex; Neuron; Prion diseases

Mesh:

Substances:

Year:  2014        PMID: 25311207     DOI: 10.1007/s12035-014-8915-2

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  32 in total

1.  CD59 blocks not only the insertion of C9 into MAC but inhibits ion channel formation by homologous C5b-8 as well as C5b-9.

Authors:  Imre Farkas; Lajos Baranyi; Yasushige Ishikawa; Noriko Okada; Csaba Bohata; Denes Budai; Atsuo Fukuda; Masaki Imai; Hidechika Okada
Journal:  J Physiol       Date:  2002-03-01       Impact factor: 5.182

2.  Complement activation in human prion disease.

Authors:  Gabor G Kovacs; Philippe Gasque; Thomas Ströbel; Elisabeth Lindeck-Pozza; Michaela Strohschneider; James W Ironside; Herbert Budka; Marin Guentchev
Journal:  Neurobiol Dis       Date:  2004-02       Impact factor: 5.996

Review 3.  The role of c5b-9 terminal complement complex in activation of the cell cycle and transcription.

Authors:  Matthew Fosbrink; Florin Niculescu; Horea Rus
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

Review 4.  Membrane attack by complement: the assembly and biology of terminal complement complexes.

Authors:  Cosmin A Tegla; Cornelia Cudrici; Snehal Patel; Richard Trippe; Violeta Rus; Florin Niculescu; Horea Rus
Journal:  Immunol Res       Date:  2011-10       Impact factor: 2.829

5.  The complement membrane attack complex triggers intracellular Ca2+ fluxes leading to NLRP3 inflammasome activation.

Authors:  Kathy Triantafilou; Timothy R Hughes; Martha Triantafilou; B Paul Morgan
Journal:  J Cell Sci       Date:  2013-04-23       Impact factor: 5.285

6.  Microvascular deposition of complement membrane attack complex in dermatomyositis.

Authors:  J T Kissel; J R Mendell; K W Rammohan
Journal:  N Engl J Med       Date:  1986-02-06       Impact factor: 91.245

7.  The cytoprotective role of Ras in complement-mediated glomerular epithelial cell injury.

Authors:  Carl Huynh; Guohui Ren; Joan Papillon; Julie Guillemette; Tomoko Takano; Andrey V Cybulsky
Journal:  Clin Immunol       Date:  2009-01-09       Impact factor: 3.969

8.  The presence of complements in amyloid plaques of Creutzfeldt-Jakob disease and Gerstmann-Straussler-Scheinker disease.

Authors:  T Ishii; S Haga; S Yagishita; J Tateishi
Journal:  Appl Pathol       Date:  1984

9.  The membrane attack complex of the complement system is essential for rapid Wallerian degeneration.

Authors:  Valeria Ramaglia; Rosalind Helen Mary King; Michelle Nourallah; Ruud Wolterman; Rosalein de Jonge; Marja Ramkema; Miriam Ann Vigar; Sandra van der Wetering; Brian Paul Morgan; Dirk Troost; Frank Baas
Journal:  J Neurosci       Date:  2007-07-18       Impact factor: 6.167

10.  Characteristics of 263K scrapie agent in multiple hamster species.

Authors:  Kimberly D Meade-White; Kent D Barbian; Brent Race; Cynthia Favara; Don Gardner; Lara Taubner; Stephen Porcella; Richard Race
Journal:  Emerg Infect Dis       Date:  2009-02       Impact factor: 6.883

View more
  14 in total

Review 1.  Microglia in prion diseases.

Authors:  Adriano Aguzzi; Caihong Zhu
Journal:  J Clin Invest       Date:  2017-07-17       Impact factor: 14.808

2.  Proteomic analysis of host brain components that bind to infectious particles in Creutzfeldt-Jakob disease.

Authors:  Terry Kipkorir; Christopher M Colangelo; Laura Manuelidis
Journal:  Proteomics       Date:  2015-06-09       Impact factor: 3.984

3.  Region-specific glial homeostatic signature in prion diseases is replaced by a uniform neuroinflammation signature, common for brain regions and prion strains with different cell tropism.

Authors:  Natallia Makarava; Jennifer Chen-Yu Chang; Kara Molesworth; Ilia V Baskakov
Journal:  Neurobiol Dis       Date:  2020-01-27       Impact factor: 5.996

4.  Proteomic Analyses for the Global S-Nitrosylated Proteins in the Brain Tissues of Different Human Prion Diseases.

Authors:  Li-Na Chen; Qi Shi; Bao-Yun Zhang; Xiao-Mei Zhang; Jing Wang; Kang Xiao; Yan Lv; Jing Sun; Xiao-Dong Yang; Cao Chen; Wei Zhou; Jun Han; Xiao-Ping Dong
Journal:  Mol Neurobiol       Date:  2015-09-21       Impact factor: 5.590

Review 5.  Let's make microglia great again in neurodegenerative disorders.

Authors:  Marie-Victoire Guillot-Sestier; Terrence Town
Journal:  J Neural Transm (Vienna)       Date:  2017-10-12       Impact factor: 3.575

6.  Alternative complement pathway is activated in the brains of scrapie-infected rodents.

Authors:  Cao Chen; Yan Lv; Chao Hu; Xiao-Feng Xu; Ren-Qing Zhang; Kang Xiao; Yue Ma; Li-Ping Gao; Jian-Le Li; Qiang Shi; Jing Wang; Qi Shi; Xiao-Ping Dong
Journal:  Med Microbiol Immunol       Date:  2019-11-12       Impact factor: 3.402

7.  The associations of two SNPs in miRNA-146a and one SNP in ZBTB38-RASA2 with the disease susceptibility and the clinical features of the Chinese patients of sCJD and FFI.

Authors:  Chen Gao; Qiang Shi; Jing Wei; Wei Zhou; Kang Xiao; Jing Wang; Qi Shi; Xiao-Ping Dong
Journal:  Prion       Date:  2018-01-02       Impact factor: 3.931

8.  Increases of Galectin-1 and its S-nitrosylated form in the Brain Tissues of Scrapie-Infected Rodent Models and Human Prion Diseases.

Authors:  Yan-Jun Guo; Qi Shi; Xiao-Dong Yang; Jian-Le Li; Yue Ma; Kang Xiao; Cao Chen; Jun Han; Xiao-Ping Dong
Journal:  Mol Neurobiol       Date:  2016-05-23       Impact factor: 5.590

9.  Prion potentiation after life-long dormancy in mice devoid of PrP.

Authors:  Davy Martin; Fabienne Reine; Laetitia Herzog; Angélique Igel-Egalon; Naima Aron; Christel Michel; Mohammed Moudjou; Guillaume Fichet; Isabelle Quadrio; Armand Perret-Liaudet; Olivier Andréoletti; Human Rezaei; Vincent Béringue
Journal:  Brain Commun       Date:  2021-04-28

10.  Ablation of CCAAT/Enhancer-Binding Protein Delta (C/EBPD): Increased Plaque Burden in a Murine Alzheimer's Disease Model.

Authors:  Manuel Lutzenberger; Michael Burwinkel; Constanze Riemer; Victoria Bode; Michael Baier
Journal:  PLoS One       Date:  2015-07-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.